Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1983 1
2004 1
2005 1
2006 1
2008 1
2009 1
2010 6
2011 3
2012 6
2013 4
2014 5
2015 13
2016 9
2017 6
2018 9
2019 7
2020 17
2021 11
2022 14
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20Nasr, 20Isfahani
Page 1
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.
Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, Metra M, Ponikowski P, Sliwa K, Voors AA, Edwards C, Novosadova M, Takagi K, Damasceno A, Saidu H, Gayat E, Pang PS, Celutkiene J, Cotter G. Mebazaa A, et al. Lancet. 2022 Dec 3;400(10367):1938-1952. doi: 10.1016/S0140-6736(22)02076-1. Epub 2022 Nov 7. Lancet. 2022. PMID: 36356631 Clinical Trial.
As of data cutoff (Oct 13, 2022), by day 90, a higher proportion of patients in the high-intensity care group had been up-titrated to full doses of prescribed drugs (renin-angiotensin blockers 278 [55%] of 505 vs 11 [2%] of 497; beta blockers 249 [49%] vs 20 [4%]; and mine …
As of data cutoff (Oct 13, 2022), by day 90, a higher proportion of patients in the high-intensity care group had been up-titrated to full d …
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Neurology Collaborators. GBD 2016 Neurology Collaborators. Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14. Lancet Neurol. 2019. PMID: 30879893 Free PMC article.
The four largest contributors of neurological DALYs were stroke (42.2% [38.6-46.1]), migraine (16.3% [11.7-20.8]), Alzheimer's and other dementias (10.4% [9.0-12.1]), and meningitis (7.9% [6.6-10.4]). For the combined neurological disorders, age-standardised DALY rates wer …
The four largest contributors of neurological DALYs were stroke (42.2% [38.6-46.1]), migraine (16.3% [11.7-20.8]), Alzheimer's and ot …
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 DALYs and HALE Collaborators. GBD 2017 DALYs and HALE Collaborators. Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3. Lancet. 2018. PMID: 30415748 Free PMC article.
The increase in years of life varied from 5.1 years (5.0-5.3) in high SDI countries to 12.0 years (11.3-12.8) in low SDI countries. Of the additional years of life expected at birth, 26.3% (20.1-33.1) were expected to be spent in poor health in high SDI countries compared …
The increase in years of life varied from 5.1 years (5.0-5.3) in high SDI countries to 12.0 years (11.3-12.8) in low SDI countries. Of the a …
The impact of curcumin on migraine: A comprehensive review.
Heidari H, Shojaei M, Askari G, Majeed M, Bagherniya M, Barreto GE, Sahebkar A. Heidari H, et al. Biomed Pharmacother. 2023 Aug;164:114910. doi: 10.1016/j.biopha.2023.114910. Epub 2023 May 22. Biomed Pharmacother. 2023. PMID: 37216708 Free article. Review.
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study.
GlobalSurg Collaborative and NIHR Global Health Research Unit on Global Surgery. GlobalSurg Collaborative and NIHR Global Health Research Unit on Global Surgery. Lancet Glob Health. 2022 Jul;10(7):e1003-e1011. doi: 10.1016/S2214-109X(22)00168-1. Epub 2022 May 24. Lancet Glob Health. 2022. PMID: 35623378 Free PMC article.
FINDINGS: Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to …
FINDINGS: Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countri …
Management of Crohn's disease.
Kammermeier J, Morris MA, Garrick V, Furman M, Rodrigues A, Russell RK; BSPGHAN IBD Working Group. Kammermeier J, et al. Arch Dis Child. 2016 May;101(5):475-80. doi: 10.1136/archdischild-2014-307217. Epub 2015 Nov 9. Arch Dis Child. 2016. PMID: 26553907 Free PMC article. Review.
The vast majority of children will need immunosuppressant treatment and around 20% will need treatment with biologics. Recent guidelines have helped make best use of available therapies....
The vast majority of children will need immunosuppressant treatment and around 20% will need treatment with biologics. Recent guideli …
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: A sub-analysis of the STRONG-HF randomized clinical trial.
Arrigo M, Biegus J, Asakage A, Mebazaa A, Davison B, Edwards C, Adamo M, Barros M, Celutkiene J, Čerlinskaitė-Bajorė K, Chioncel O, Damasceno A, Diaz R, Filippatos G, Gayat E, Kimmoun A, Lam CSP, Metra M, Novosadova M, Pagnesi M, Pang PS, Ponikowski P, Saidu H, Sliwa K, Takagi K, Ter Maaten JM, Tomasoni D, Voors AA, Cotter G, Cohen-Solal A. Arrigo M, et al. Eur J Heart Fail. 2023 Jul;25(7):1145-1155. doi: 10.1002/ejhf.2920. Epub 2023 Jun 7. Eur J Heart Fail. 2023. PMID: 37246591 Clinical Trial.
HIC induced larger improvements in quality of life to day 90 in younger (EQ-VAS adjusted-mean difference 5.51, 95% CI 3.20-7.82) than in older patients (1.77, 95% CI -0.75 to 4.29, interaction p = 0.032). ...
HIC induced larger improvements in quality of life to day 90 in younger (EQ-VAS adjusted-mean difference 5.51, 95% CI 3.20-7.82) than …
PM10 and Pseudomonas aeruginosa: effects on corneal epithelium.
Somayajulu M, McClellan SA, Muhammed F, Wright R, Hazlett LD. Somayajulu M, et al. Front Cell Infect Microbiol. 2023 Oct 5;13:1240903. doi: 10.3389/fcimb.2023.1240903. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37868351 Free PMC article.
HCET were exposed to 100mug/ml PM(10) for 24h before challenge with strain 19660 (MOI 20). A subset of cells were pre-treated with 50nM SKQ1 for 1h before PM(10) exposure. ...
HCET were exposed to 100mug/ml PM(10) for 24h before challenge with strain 19660 (MOI 20). A subset of cells were pre-treated with 50 …
Steroids for symptom control in infectious mononucleosis.
Rezk E, Nofal YH, Hamzeh A, Aboujaib MF, AlKheder MA, Al Hammad MF. Rezk E, et al. Cochrane Database Syst Rev. 2015 Nov 8;2015(11):CD004402. doi: 10.1002/14651858.CD004402.pub3. Cochrane Database Syst Rev. 2015. PMID: 26558642 Free PMC article. Review.
Two trials found benefit of steroid therapy over placebo in reducing sore throat at 12 hours (eight-day course odds ratio (OR) 21.00, 95% confidence interval (CI) 1.94 to 227.20; one-dose OR 4.20, 95% CI 1.08 to 16.32), but the benefit was not maintained.In combinat …
Two trials found benefit of steroid therapy over placebo in reducing sore throat at 12 hours (eight-day course odds ratio (OR) 21.00, 95% co …
121 results